![Mark Lanasa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Lanasa
Corporate Officer/Principal bij
BEIGENE LTD
Profiel
Mark Lanasa currently works at BeOne Medicines Ltd., as Chief Medical Officer-Solid Tumors & SVP from 2022.
Mr. Lanasa also formerly worked at AstraZeneca PLC, as Vice President & Head-Enhertu Global Clinical from 2019 to 2022.
Mr. Lanasa received his undergraduate degree from The Pennsylvania State University and graduate degree and doctorate degree from the University of Pittsburgh School of Medicine.
Actieve functies van Mark Lanasa
| Bedrijven | Functie | Begin |
|---|---|---|
| BEIGENE LTD | Corporate Officer/Principal | 09-02-2022 |
Eerdere bekende functies van Mark Lanasa
| Bedrijven | Functie | Einde |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01-01-2022 |
Opleiding van Mark Lanasa
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
19
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pittsburgh School of Medicine
 University of Pittsburgh School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
